Filing Flows

Filing Flows › Comparisons › VYCO vs HRGN

Vycor Medical vs Harvard Apparatus Regenerative Technology: VYCO and HRGN compared

Vycor Medical is the larger company: $418K of revenue in its latest quarter (Q2 2026) against $414K for Harvard Apparatus Regenerative Technology (Q2 2026). Harvard Apparatus Regenerative Technology is growing faster (+31% against -16% a year earlier). Vycor Medical is more profitable, with an operating margin of 1.6% against -408.7%.

Vycor Medical vs Harvard Apparatus Regenerative Technology, latest quarterVycor Medical vs Harvard Apparatus Regenerative Technology, latest quarterVycor Medical (VYCO)Harvard Apparatus Regenerative Technology (HRGN)Revenue$418K$414KRevenue growth, Y/Y-16%+31%Operating margin1.6%-408.7%Net margin-5.3%-409.4%

Where the money goes: VYCO and HRGN

Vycor Medical (VYCO) · Q2 2026

Vycor Medical, Q2 2026: revenue $418K (-16% year over year), operating margin 1.6%, net loss $22K, operating cash flow −$5K. The chart follows the revenue to costs, profit and cash.

Harvard Apparatus Regenerative Technology (HRGN) · Q2 2026

Harvard Apparatus Regenerative Technology, Q2 2026: revenue $414K (+31% year over year), operating margin -408.7%, net loss $1.7M, operating cash flow −$569K. The chart follows the revenue to costs, profit and cash.

Vycor Medical revenue by segment, Q2 2026Vycor Medical revenue by segment, Q2 2026Vycor Medical Inc$401KNovaVision Inc$17K
Vycor Medical (VYCO)Harvard Apparatus Regenerative Technology (HRGN)
Latest quarterQ2 2026Q2 2026
Revenue$418K$414K
Revenue growth, Y/Y-16%+31%
Operating margin1.6%-408.7%
Net earnings−$22K−$1.7M
Net margin-5.3%-409.4%
Operating cash flow−$5K−$569K

Where the revenue comes from

Vycor Medical

Questions

Which is bigger, Vycor Medical or Harvard Apparatus Regenerative Technology?

Vycor Medical is the larger company: $418K of revenue in its latest quarter (Q2 2026) against $414K for Harvard Apparatus Regenerative Technology (Q2 2026).

Is Vycor Medical or Harvard Apparatus Regenerative Technology growing faster?

Harvard Apparatus Regenerative Technology is growing faster (+31% against -16% a year earlier).

Which is more profitable, Vycor Medical or Harvard Apparatus Regenerative Technology?

Vycor Medical is more profitable, with an operating margin of 1.6% against -408.7%.

More: Vycor Medical earnings · how Vycor Medical makes money · Harvard Apparatus Regenerative Technology earnings · how Harvard Apparatus Regenerative Technology makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.